• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

痛风综述:回顾与展望

A review on gout: Looking back and looking ahead.

作者信息

Tao Haolin, Mo Yingshi, Liu Wenbin, Wang Hui

机构信息

College of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou 510006, China.

Guangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances, Guangdong Pharmaceutical University, Guangzhou 510006, China.

出版信息

Int Immunopharmacol. 2023 Apr;117:109977. doi: 10.1016/j.intimp.2023.109977. Epub 2023 Mar 9.

DOI:10.1016/j.intimp.2023.109977
PMID:37012869
Abstract

Gout is a metabolic disease caused by the deposition of monosodium urate (MSU) crystals inside joints, which leads to inflammation and tissue damage. Increased concentration of serum urate is an essential step in the development of gout. Serum urate is regulated by urate transporters in the kidney and intestine, especially GLUT9 (SLC2A9), URAT1 (SLC22A12) and ABCG. Activation of NLRP3 inflammasome bodies and subsequent release of IL-1β by monosodium urate crystals induce the crescendo of acute gouty arthritis, while neutrophil extracellular traps (NETs) are considered to drive the self-resolving of gout within a few days. If untreated, acute gout may eventually develop into chronic tophaceous gout characterized by tophi, chronic gouty synovitis, and structural joint damage, leading the crushing burden of treatment. Although the research on the pathological mechanism of gout has been gradually deepened in recent years, many clinical manifestations of gout are still unable to be fully elucidated. Here, we reviewed the molecular pathological mechanism behind various clinical manifestations of gout, with a view to making contributions to further understanding and treatment.

摘要

痛风是一种由单钠尿酸盐(MSU)晶体在关节内沉积引起的代谢性疾病,可导致炎症和组织损伤。血清尿酸浓度升高是痛风发展的关键步骤。血清尿酸由肾脏和肠道中的尿酸转运蛋白调节,尤其是葡萄糖转运蛋白9(GLUT9,SLC2A9)、尿酸盐转运蛋白1(URAT1,SLC22A12)和ATP结合盒转运体G(ABCG)。单钠尿酸盐晶体激活NLRP3炎性小体并随后释放白细胞介素-1β,引发急性痛风性关节炎的加重,而中性粒细胞胞外陷阱(NETs)被认为在数天内推动痛风的自行缓解。若不治疗,急性痛风最终可能发展为慢性痛风石性痛风,其特征为痛风石、慢性痛风性滑膜炎和关节结构损伤,带来沉重的治疗负担。尽管近年来对痛风病理机制的研究逐渐深入,但痛风的许多临床表现仍无法得到充分阐释。在此,我们综述了痛风各种临床表现背后的分子病理机制,以期为进一步的理解和治疗提供帮助。

相似文献

1
A review on gout: Looking back and looking ahead.痛风综述:回顾与展望
Int Immunopharmacol. 2023 Apr;117:109977. doi: 10.1016/j.intimp.2023.109977. Epub 2023 Mar 9.
2
Molecular Pathophysiology of Gout.痛风的分子病理生理学。
Trends Mol Med. 2017 Aug;23(8):756-768. doi: 10.1016/j.molmed.2017.06.005. Epub 2017 Jul 18.
3
Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans.在人类中,血浆尿酸水平由电压驱动的尿酸外流转运体URATv1(SLC2A9)直接调节。
J Biol Chem. 2008 Oct 3;283(40):26834-8. doi: 10.1074/jbc.C800156200. Epub 2008 Aug 13.
4
Urate transport capacity of glucose transporter 9 and urate transporter 1 in cartilage chondrocytes.葡萄糖转运蛋白 9 和尿酸转运蛋白 1 在软骨细胞中的尿酸转运能力。
Mol Med Rep. 2019 Aug;20(2):1645-1654. doi: 10.3892/mmr.2019.10426. Epub 2019 Jun 25.
5
Gout.痛风。
Lancet. 2021 May 15;397(10287):1843-1855. doi: 10.1016/S0140-6736(21)00569-9. Epub 2021 Mar 30.
6
GLUT9 influences uric acid concentration in patients with Lesch-Nyhan disease.葡萄糖转运蛋白9影响莱施-奈恩病患者的尿酸浓度。
Int J Rheum Dis. 2018 Jun;21(6):1270-1276. doi: 10.1111/1756-185X.13323.
7
Engagement of fatty acids with Toll-like receptor 2 drives interleukin-1β production via the ASC/caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritis.脂肪酸与Toll样受体2结合通过ASC/半胱天冬酶1途径在尿酸单钠晶体诱导的痛风性关节炎中驱动白细胞介素-1β的产生。
Arthritis Rheum. 2010 Nov;62(11):3237-48. doi: 10.1002/art.27667.
8
Caspase-11 Mediates Neutrophil Chemotaxis and Extracellular Trap Formation During Acute Gouty Arthritis Through Alteration of Cofilin Phosphorylation.Caspase-11 通过改变丝切蛋白磷酸化介导向中性粒细胞趋化和急性痛风性关节炎中外周陷阱的形成。
Front Immunol. 2019 Nov 15;10:2519. doi: 10.3389/fimmu.2019.02519. eCollection 2019.
9
The biology of urate.尿酸盐的生物学。
Semin Arthritis Rheum. 2020 Jun;50(3S):S2-S10. doi: 10.1016/j.semarthrit.2020.04.007.
10
Complex analysis of urate transporters SLC2A9, SLC22A12 and functional characterization of non-synonymous allelic variants of GLUT9 in the Czech population: no evidence of effect on hyperuricemia and gout.捷克人群中尿酸转运蛋白SLC2A9、SLC22A12的综合分析及GLUT9非同义等位基因变异的功能表征:无证据表明其对高尿酸血症和痛风有影响。
PLoS One. 2014 Sep 30;9(9):e107902. doi: 10.1371/journal.pone.0107902. eCollection 2014.

引用本文的文献

1
Meridian-Sinew Release Therapy as an adjunctive treatment for gouty arthritis: a systematic review and meta-analysis.经络-经筋松解疗法作为痛风性关节炎的辅助治疗:一项系统评价和荟萃分析。
J Orthop Surg Res. 2025 Aug 18;20(1):769. doi: 10.1186/s13018-025-06123-1.
2
Gouty Arthritis Treatment: Advancements in Topical Lipid-Based Nanocarrier Delivery Systems.痛风性关节炎治疗:基于脂质的局部纳米载体递送系统的进展
Adv Pharm Bull. 2025 Apr 4;15(1):11-26. doi: 10.34172/apb.44012. eCollection 2025 Apr.
3
Decoding PANoptosis in Gout: Signature Gene Identification and Immune Infiltration Profiling.
痛风中全程序性坏死的解码:特征基因鉴定与免疫浸润分析
Int J Rheum Dis. 2025 Jul;28(7):e70344. doi: 10.1111/1756-185X.70344.
4
Serum uric acid reduction through SGLT2 inhibitors: evidence from a systematic review and meta-analysis.通过钠-葡萄糖协同转运蛋白2抑制剂降低血清尿酸:一项系统评价与荟萃分析的证据
Front Pharmacol. 2025 Jun 19;16:1551390. doi: 10.3389/fphar.2025.1551390. eCollection 2025.
5
Integrative bioinformatics analysis and experimental validation reveals key genes and regulatory mechanisms in the development of gout.整合生物信息学分析与实验验证揭示痛风发展中的关键基因和调控机制。
Front Genet. 2025 Jun 18;16:1598835. doi: 10.3389/fgene.2025.1598835. eCollection 2025.
6
Neutrophil Extracellular Traps (NETs) in Sterile Inflammatory Diseases.无菌性炎症疾病中的中性粒细胞胞外陷阱(NETs)
J Inflamm Res. 2025 Jun 17;18:7989-8004. doi: 10.2147/JIR.S526936. eCollection 2025.
7
Macrophage targeting precision nanomedicine utilizing ROS-responsive metallozyme-loaded nanomicelle for enhanced treatment of gout-induced inflammation.利用负载活性氧响应性金属酶的纳米胶束靶向巨噬细胞的精准纳米药物,用于增强痛风性炎症的治疗。
Sci Technol Adv Mater. 2025 Apr 22;26(1):2491304. doi: 10.1080/14686996.2025.2491304. eCollection 2025.
8
Sinomenine alleviates gouty inflammation by inhibiting macrophage M1 polarization and neutrophil extracellular trap formation.青藤碱通过抑制巨噬细胞M1极化和中性粒细胞胞外陷阱形成来减轻痛风性炎症。
Naunyn Schmiedebergs Arch Pharmacol. 2025 May 17. doi: 10.1007/s00210-025-04161-4.
9
Therapeutic potential and pharmacological mechanisms of Traditional Chinese Medicine in gout treatment.中药在痛风治疗中的治疗潜力及药理机制
Acta Pharmacol Sin. 2025 May;46(5):1156-1176. doi: 10.1038/s41401-024-01459-6. Epub 2025 Jan 17.
10
Impaired pulmonary function increases the risk of gout: evidence from a large cohort study in the UK Biobank.肺功能受损会增加痛风风险:来自英国生物银行一项大型队列研究的证据。
BMC Med. 2024 Dec 31;22(1):606. doi: 10.1186/s12916-024-03836-8.